This is achieved by inhibiting the enzymatic activity of USP14 and UCHL5, and VLX1570 shows significant anti‐cancer impact in multiple myeloma and Waldenstrom's macroglobulinemia.32 Here, UCHL5 is linked to Waldenstrom macroglobulinemia.